Efficacy and Safety of Mecasermin (rhIGF-1) in Patients with Reported Severe Primary IGF-I Deficiency: Updated Results from the Global Increlex® Registry

VUBIR (Vrije Universiteit Brussel) 2026

Authors: Philippe Ferdinand Backeljauw

Cited by: 0

Fields of Study & Subjects

Growth Hormone and Insulin-like Growth Factors Immunodeficiency and Autoimmune Disorders Connective tissue disorders research